PROVIDER PROFILE · NPI 1144268129
Michela CarusoM.D.
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
881
Unique beneficiaries
—
Total services
4,297
Distinct HCPCS
29
Medicare payment
$228K
Peer benchmark
Total Medicare services vs. 329 Radiation Oncology providers in TX — top quintile (cohort median 1,836).
PRESCRIBING · PART D · 2024
Total Rx claims
24
Beneficiaries
—
Total drug cost
$282
Distinct drugs
2
Brand share
45.8%
Top prescribed drugs
Tamsulosin Hcl13 claims
Silver Sulfadiazine11 claims
QUALITY · MIPS · 2024
Final MIPS score
85.1
Quality
67.5
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.43%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
Total received
$510
Payment records
23
By payment type
Food and Beverage$510
Top paying entities
Food and Beverage$510
REFERRAL NETWORK
Where Michela Caruso's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 7 inbound referrers · 12 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Jessamy Boyd Radiation Oncology · Dallas, TX | 79 | 5,236 |
| Sreenivas Chittoor Hematology-Oncology · Mesquite, TX | 24 | 1,077 |
| BAYLOR UNIVERSITY MEDICAL CENTER | 22 | 289 |
| Laboratory Corporation Of America Clinical Laboratory · Dallas, TX | 19 | 182 |
| NPI 1134127749 | 18 | 115 |
| Btdi Jv Llp Independent Diagnostic Testing Facility (IDTF) · Mesquite, TX | 13 | 53 |
| Pathologists Bio-Medical Laboratories Pllc Clinical Laboratory · Coppell, TX | 13 | 241 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| Jessamy Boyd Radiation Oncology · Dallas, TX | 80 | 5,622 |
| CLEARPOINT DIAGNOSTIC LABORATORIES, LLC | 69 | 752 |
| Sreenivas Chittoor Hematology-Oncology · Mesquite, TX | 25 | 1,306 |
| BAYLOR UNIVERSITY MEDICAL CENTER | 18 | 138 |
| Sudha Teerdhala Medical Oncology · Mesquite, TX | 17 | 749 |
| Laboratory Corporation Of America Clinical Laboratory · Dallas, TX | 16 | 187 |
| NPI 1134127749 | 15 | 132 |
| Michael Valachovic Internal Medicine · Dallas, TX | 15 | 317 |
| Quest Diagnostics Clinical Laboratories Inc Clinical Laboratory · Irving, TX | 13 | 81 |
| Victor Horadam Medical Oncology · Mesquite, TX | 13 | 819 |
| COLUMBIA HOSPITAL AT MEDICAL CITY DALLAS SUBSIDIARY LP | 12 | 116 |
| Shiela Haffar Medical Oncology · Mesquite, TX | 11 | 1,028 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE